NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer.

The predictive ability of the model was measured by internal validation (R 2 Y= 0.791, Q 2 = 0.601, CV-ANOVA p -value < 0.01), suggesting that the model possessed a satisfactory fit with good predictive power, and the metabolite differences between the groups within the model were highly significant.

also in 132,142 other papers